Prothena Corp Public (PRTA) Assets (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly Assets of $349.9 million for Q1 2026, down 29.36% year-over-year from $495.3 million in Q1 2025, and up 7.07% quarter-over-quarter from $326.8 million in Q4 2025.
Prothena Corp Public (PRTA) Assets (2012 - 2026) Analysis & Trends
Prothena Corp Public's Assets history runs 15 years deep, the most recent figure standing at $349.9 million for Q1 2026.
- In Q1 2026, Assets fell 29.36% year-over-year to $349.9 million; the TTM figure through Mar 2026 stood at $349.9 million (down 29.36% YoY), while the FY2025 annual figure was $326.8 million, down 40.27% from the prior year.
- Assets for Q1 2026 stood at $349.9 million, up from $326.8 million in the prior quarter.
- The five-year high for Assets was $758.0 million in Q4 2022, with the low at $326.8 million in Q4 2025.
- The 5-year median for Assets is $581.4 million (2022), against an average of $569.6 million.
- The sharpest annual moves came in 2022 and 2025: Assets jumped 53.12% in 2022, then slumped 40.76% in 2025.
- Prothena Corp Public's Assets stood at $758.0 million in 2022, then decreased by 8.13% to $696.4 million in 2023, then decreased by 21.44% to $547.1 million in 2024, then plunged by 40.27% to $326.8 million in 2025, then gained by 7.07% to $349.9 million in 2026.
- Business Quant data shows PRTA's Assets at $349.9 million in Q1 2026, $326.8 million in Q4 2025, and $352.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | 302.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 302.58 Mn |
| Mar 31, 2026 | 349.89 Mn |
| Dec 31, 2025 | 326.80 Mn |
| Sep 30, 2025 | 352.63 Mn |
| Jun 30, 2025 | 399.07 Mn |
| Mar 31, 2025 | 495.34 Mn |
| Dec 31, 2024 | 547.11 Mn |
| Sep 30, 2024 | 595.25 Mn |
| Jun 30, 2024 | 645.57 Mn |
| Mar 31, 2024 | 623.19 Mn |
| Dec 31, 2023 | 696.38 Mn |
| Sep 30, 2023 | 746.92 Mn |
| Jun 30, 2023 | 720.65 Mn |
| Mar 31, 2023 | 741.59 Mn |
| Dec 31, 2022 | 758.04 Mn |
| Sep 30, 2022 | 554.44 Mn |
| Jun 30, 2022 | 549.59 Mn |
| Mar 31, 2022 | 581.41 Mn |
| Dec 31, 2021 | 609.37 Mn |
| Sep 30, 2021 | 632.70 Mn |